<DOC>
	<DOC>NCT02805881</DOC>
	<brief_summary>Safety and Feasibility of Combined Trigeminal and Occipital Transcutaneous Nerve Stimulation (CTO-TNS) in Major Depressive Disorder (MDD)</brief_summary>
	<brief_title>Safety and Feasibility of Combined Trigeminal and Occipital Transcutaneous Nerve Stimulation (CTO-TNS) in Major Depressive Disorder (MDD)</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder, Major</mesh_term>
	<criteria>The subject is capable of understanding the study and to sign an informed consent. Subject is between the ages of 18 to 65 years old. Unipolar major depressive disorder Score on the Hamilton Depression Rating Scale (HDRS21) &gt; 22 Current MDD episode &gt;3 months Nonresponse with &gt;6 week use of one to six antidepressant in current episode History of neurosurgical interventions. Subjects with metal implants or shrapnel in their head, except for dental implants. Skin lesion or inflammation at the region of the stimulating electrodes. Pregnancy or Lactation. Women of reproductive age not using efficient contraceptive method. History of cerebrovascular event. Psychotic or bipolar depression History of schizophrenia, schizoaffective disorder or other nonmood disorder psychosis Current delirium, dementia, amnestic disorder or other cognitive disorders Clinically significant current suicidal intent as assessed by the investigator team. Obsessivecompulsive disorder or posttraumatic stress disorder Alcohol and nonalcohol psychoactive substance abuse or dependence Significant cardiac, medical, or progressive neurological or medical illness An implantable electrical device such as a pacemaker.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>